To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- Positive top-line phase III data in type 2 diabetes achieved for lixisenatide once-daily vs. exenatide twice-daily - Lixisenatide meets primary efficacy endpoint with fewer hypoglycaemias
- Split_Brain
- Advanced Biotherapy and Innogenetics Combine Intellectual Property on Antibodies to Interferon-Gamma